Copper-triggered aggregation of ubiquitin

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Arnesano, Fabio ^a   Scintilla, Simone ^a   Calò, Vincenza ^b   Bonfrate, Elena ^a   Ingrosso, Chiara ^a   Losacco, Maurizio ^a   Pellegrino, Teresa ^c   Rizzarelli, Enrico ^d   Natile, Giovanni ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici ^*  (Italy)

^c NATIONAL NANOTECHNOLOGY LABORATORY   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; AMYLOID; COPPER; CUPRIC ION; DIMER; OLIGOMER; UBIQUITIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; BILAYER MEMBRANE; CHELATION; CIRCULAR DICHROISM; CONTROLLED STUDY; DIELECTRIC CONSTANT; GEL ELECTROPHORESIS; HUMAN; INCUBATION TIME; INFRARED SPECTROSCOPY; PROTEIN AGGREGATION; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; CELL MEMBRANE; CHELATING AGENTS; COPPER; ELECTROCHEMISTRY; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR CONFORMATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; UBIQUITIN;

EID: 75549083286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007052     Document Type: Article

References (70)

1. McClellan AJ, Tam S, Kaganovich D, Frydman J (2005) Protein quality control: chaperones culling corrupt conformations. Nat Cell Biol 7: 736-741.
2. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479.
3. Pickart CM, Fushman D (2004) Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 8: 610-616.
4. Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4: 49-60.
5. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366.
6. Brown DR, Qin K, Herms JW, Madlung A, Manson J, et al. (1997) The cellular prion protein binds copper in vivo. Nature 390: 684-687.
7. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, et al. (1998) Dramatic aggregation of Alzheimer Ab by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273: 12817-12826.
8. Paik SR, Shin HJ, Lee JH, Chang CS, Kim J (1999) Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem J 340: 821-828.
9. Morgan CJ, Gelfand M, Atreya C, Miranker AD (2001) Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J Mol Biol 309: 339-345.
10. Amici M, Forti K, Nobili C, Lupidi G, Angeletti M, et al. (2002) Effect of neurotoxic metal ions on the proteolytic activities of the 20S proteasome from bovine brain. J Biol Inorg Chem 7: 750-756.
11. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, et al. (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 155: 9-15.
12. Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40: 427-446.
13. Ross CA, Pickart CM (2004) The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol 14: 703-711.
14. Lowe J, Hand N, Mayer RJ (2005) Application of ubiquitin immunohistochemistry to the diagnosis of disease. Methods Enzymol 399: 86-119.
15. Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27: 494-506.
16. Uversky VN, Li J, Fink AL (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure. J Biol Chem 276: 44284-44296.
17. Binolfi A, Rasia RM, Bertoncini CW, Ceolin M, Zweckstetter M, et al. (2006) Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. J Am Chem Soc 128: 9893-9901.
18. Wright JA, Brown DR (2008) Alpha-synuclein and its role in metal binding: relevance to Parkinson's disease. J Neurosci Res 86: 496-503.
19. Jackson SE (2006) Ubiquitin: a small protein folding paradigm. Org Biomol Chem 4: 1845-1853.
20. Milardi D, Arnesano F, Grasso G, Magrì A, Tabbì G, et al. (2007) Ubiquitin stability and the Lys63-linked polyubiquitination site are compromised on copper binding. Angew Chem Int Ed Engl 46: 7993-7995.
21. Gaggelli E, Kozlowski H, Valensin D, Valensin G (2006) Copper homeostasis and neurodegenerative disorders (Alzheimer's, Prion, and Parkinson's diseases and Amyotrophic Lateral Sclerosis). Chem Rev 106: 1995-2044.
22. Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, et al. (2005) Structural characterization of copper(II) binding to a-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. Proc Natl Acad Sci U S A 102: 4294-4299.
23. Trovato A, Chiti F, Maritan A, Seno F (2006) Insight into the structure of amyloid fibrils from the analysis of globular proteins. PLoS Comput Biol 2: e170.
24. Munishkina LA, Phelan C, Uversky VN, Fink AL (2003) Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. Biochemistry 42: 2720-2730.
25. Chiti F, Webster P, Taddei N, Clark A, Stefani M, et al. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A 96: 3590-3594.
26. 2-microglobulin fragment are induced by fluorine-substituted alcohols. J Mol Biol 363: 279-288.
27. Hawe A, Sutter M, Jiskoot W (2008) Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res 25: 1487-1499.
28. Hess S, Lindquist SL, Scheibel T (2007) Alternative assembly pathways of the amyloidogenic yeast prion determinant Sup35-NM. EMBO Rep 8: 1196-1201.
29. Parag HA, Raboy B, Kulka RG (1987) Effect of heat shock on protein degradation in mammalian cells: involvement of the ubiquitin system. EMBO J 6: 55-61.
30. Ryu KY, Garza JC, Lu XY, Barsh GS, Kopito RR (2008) Hypothalamic neurodegeneration and adult-onset obesity in mice lacking the Ubb poly-ubiquitin gene. Proc Natl Acad Sci U S A 105: 4016-4021.
31. Sixt SU, Dahlmann B (2008) Extracellular, circulating proteasomes and ubiquitin - incidence and relevance. Biochim Biophys Acta 1782: 817-823.
32. Zandomeneghi G, Krebs MR, McCammon MG, Fandrich M (2004) FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci 13: 3314-3321.
33. Lowe R, Pountney DL, Jensen PH, Gai WP, Voelcker NH (2004) Calcium(II) selectively induces alpha-synuclein annular oligo via interaction with the C-terminal domain. Protein Sci 13: 3245-3252.
34. Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, et al. (2005) Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J Biol Chem 280: 9678-9690.
35. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
36. 2+ increase in primary neuronal cells. J Biol Chem 283: 29950-29960.
37. Lashuel HA (2005) Membrane permeabilization: a common mechanism in protein-misfolding diseases. Sci Aging Knowledge Environ 2005: e28.
38. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, et al. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97: 571-576.
39. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349.
40. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT (2002) Neurodegenerative disease - Amyloid pores from pathogenic mutations. Nature 418: 291.
41. Herrera FE, Chesi A, Paleologou KE, Schmid A, Munoz A, et al. (2008) Inhibition of alpha-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region. PLoS ONE 3: e3394.
42. Bennett EJ, Bence NF, Jayakumar R, Kopito RR (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17: 351-365.
43. Lee JC, Gray HB, Winkler JR (2008) Copper(II) binding to alpha-synuclein, the Parkinson's protein. J Am Chem Soc 130: 6898-6899.
44. Vijay-Kumar S, Bugg CE, Cook WJ (1987) Structure of ubiquitin refined at 1.8 Å reolution. J Mol Biol 194: 531-544.
45. Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, et al. (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17: 431-439.
46. Maryon EB, Molloy SA, Zimnicka AM, Kaplan JH (2007) Copper entry into human cells: progress and unanswered questions. Biometals 20: 355-364.
47. Lee J, Petris MJ, Thiele DJ (2002) Characterization of mouse embryonic cells deficient in the Ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J Biol Chem 277: 40253-40259.
48. Moriya M, Ho YH, Grana A, Nguyen L, Alvarez A, et al. (2008) Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism. Am J Physiol Cell Physiol 295: C708-C721.
49. Pufahl RA, Singer CP, Peariso KL, Lin S-J, Schmidt PJ, et al. (1997) Metal ion chaperone function of the soluble Cu(I) receptor Atx1. Science 278: 853-856.
50. Xiao Z, Loughlin F, George GN, Howlett GJ, Wedd AG (2004) C-terminal domain of the membrane copper transporter Ctr1 from Saccharomyces cerevisiae binds four Cu(I) ions as a cuprous-thiolate polynuclear cluster: sub-femtomolar Cu(I) affinity of three proteins involved in copper trafficking. J Am Chem Soc 126: 3081-3090.
51. Yang L, McRae R, Henary MM, Patel R, Lai B, et al. (2005) Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron x-ray fluorescence microscopy. Proc Natl Acad Sci U S A 102: 11179-11184.
52. Chwiej J, Adamek D, Szczerbowska-Boruchowska M, Krygowska-Wajs A, Bohic S, et al. (2008) Study of Cu chemical state inside single neurons from Parkinson's disease and control substantia nigra using the micro-XANES technique. J Trace Elem Med Biol 22: 183-188.
53. Rees EM, Thiele DJ (2007) Identification of a vacuole-associated metallo-reductase and its role in Ctr2-mediated intracellular copper mobilization. J Biol Chem 282: 21629-21638.
54. Doherty FJ, Osborn NU, Wassell JA, Heggie PE, Laszlo L, et al. (1989) Ubiquitin-protein conjugates accumulate in the lysosomal system of fibroblasts treated with cysteine proteinase inhibitors. Biochem J 263: 47-55.
55. Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, et al. (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11: 219-225.
56. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158: 47-52.
57. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, et al. (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol 155: 30-37.
58. Ide-Ektessabi A, Rabionet M (2005) The role of trace metallic elements in neurodegenerative disorders: quantitative analysis using XRF and XANES spectroscopy. Anal Sci 21: 885-892.
59. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, et al. (1999) Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274: 23223-23228.
60. Donnelly PS, Xiao Z, Wedd AG (2007) Copper and Alzheimer's disease. Curr Opin Chem Biol 11: 128-133.
61. Barnham KJ, Bush AI (2008) Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 12: 222-228.
62. Liang X, Campopiano DJ, Sadler PJ (2007) Metals in membranes. Chem Soc Rev 36: 968-992.
63. Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, et al. (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166: 324-333.
64. Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, et al. (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 37: 583-595.
65. Quist A, Doudevski I, Lin H, Azimova R, Ng D, et al. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102: 10427-10432.
66. Wang AC, Grzesiek S, Tschudin R, Lodi PJ, Bax A (1995) Sequential backbone assignment of isotopically enriched proteins in D2O by deuterium-decoupled HA(CA)N and HA(CACO)N. J Biomol NMR 5: 376-382.
67. 13C-relaxation studies of randomly fractionally labeled protein. Biochemistry 35: 6116-6125.
68. Palmer AG III, Cavanagh J, Wright PE, Rance M (1991) Sensitivity improvement in proton-detected two dimensional heteronuclear correlation NMR spectroscopy. J Magn Reson 93: 151-170.
69. Kay LE, Keifer P, Saarinen T (1992) Pure Absorption Gradient Enhanced Heteronucler Single Quantum Correlation Spectroscopy with Improved Sensitivity. J Am Chem Soc 114: 10663-10665.
70. Morrissey JH (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 117: 307-310.